Meeting
2021 Gastrointestinal Cancers Symposium
Dissecting novel mechanisms of hepatitis B virus-related hepatocellular carcinoma using meta-analysis of public data.
Authors
Jihad Aljabban
The Ohio State University College of Medicine, Columbus, OH
Jihad Aljabban , Michael Rohr , Saad A Syed , Eli Cohen , Naima Hashi , Sharjeel Syed , Kamal Khorfan , Emmanuel Boateng , Mary Nemer , Maryam Panahiazar , Dexter Hadley , Sajid Jalil , Khalid Mumtaz , Hisham Aljabban
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Hepatobiliary Cancer
Track
Hepatobiliary Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 333)
DOI
10.1200/JCO.2021.39.3_suppl.333
Abstract #
333
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Autologous cytotoxic T-cell receptor T cell therapy (SCG101) against hepatitis B surface antigen phase I/II trial for patients with advanced hepatitis B-related hepatocellular carcinoma.
First Author: Ghassan K. Abou-Alfa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The impact of viral etiology in yttrium-90–treated hepatocellular carcinoma.
First Author: Itamar Marie Naveh-Benjamin
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical outcomes in patients (pts) with previously treated advanced hepatocellular carcinoma (HCC) experiencing hepatitis B virus (HBV) DNA increases during tislelizumab (TIS) treatment in RATIONALE-208.
First Author: Ann-Lii Cheng
Poster
2020 Gastrointestinal Cancers Symposium
Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2.
First Author: Peter R. Galle